Back
MarineMax, Inc. 10K Form
Sell
38
HZO
MarineMax, Inc.
Last Price:
$24.02
Seasonality Move:
12.06%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-25 | 10Q | HZO/MarineMax, Inc. Quarterly |
| 2024-01-25 | 10Q | HZO/MarineMax, Inc. Quarterly |
| 2023-07-27 | 10Q | HZO/MarineMax, Inc. Quarterly |
| 2023-04-27 | 10Q | HZO/MarineMax, Inc. Quarterly |
| 2023-01-31 | 10Q | HZO/MarineMax, Inc. Quarterly |
| 2022-07-28 | 10Q | HZO/MarineMax, Inc. Quarterly |
Receive HZO News And Ratings
See the #1 stock for the next 7 days that we like better than HZO
HZO Financial Statistics
Sales & Book Value
| Annual Sales: | $2.3B |
|---|---|
| Cash Flow: | $48M |
| Price / Cash Flow: | 45.08 |
| Annual Sales: | $42.86 |
| Price / Book: | 0.56 |
Profitability
| EPS (TTM): | -1.54950 |
|---|---|
| Net Income (TTM): | $-30.8M |
| Gross Margin: | $750.2M |
| Return on Equity: | -3.14% |
| Return on Assets: | -1.19% |
MarineMax, Inc. Earnings Forecast
Key MarineMax, Inc. Financial Ratios
-
The Gross Profit Margin over the past 30 years for HZO is 32.49%.
-
The Selling, General & Administrative Expenses for HZO have been equal to 28.02% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Net Earning history of HZO is -1.33% of Total Revenues.
-
Per Share Earnings over the last 30 years have been positive in 18 years.
MarineMax, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Specialty Retail |
| Sector: | Consumer Discretionary |
| Current Symbol: | HZO |
| CUSIP: | 567908 |
| Website: | marinemax.com |
Debt
| Debt-to-Equity Ratio: | 1.33 |
|---|---|
| Current Ratio: | 1.2 |
| Quick Ratio: | 0.26 |
Price-to-Earnings
| Trailing P/E Ratio: | 14.05 |
|---|---|
| Forward P/E Ratio: | 14.92 |
HZO Technical Analysis vs Fundamental Analysis
Sell
38
MarineMax, Inc. (HZO)
is a Sell
Is MarineMax, Inc. a Buy or a Sell?
-
MarineMax, Inc. stock is rated a SellThe current MarineMax, Inc. [HZO] share price is $24.01. The Score for HZO is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.